Source: Fox News
Summary
Researchers at the University of Oklahoma have discovered a hormone called FGF21 that appears to reverse obesity in the body. The hormone signals to a brain region involved in metabolism and appetite regulation, similar to the popular GLP-1 drugs. FGF21 is already involved in the development of a drug to treat fatty liver disease and may have potential for treating obesity. However, experts caution that the study was conducted in mice and its effectiveness in humans is unclear.
Our Reading
The advice sounds familiar. FGF21 is the latest hormone to be touted as a potential solution for obesity. While the study’s findings are promising, experts warn that the results may not translate to humans. The brain circuit behind FGF21’s metabolic benefits is complex, and side effects like gastrointestinal issues and bone loss are a concern. The hormone’s effectiveness in humans is still unclear, and more studies are needed to explore its potential.
It’s a story we’ve heard before: a new discovery, a new hope, and a new cycle of research and development. The FGF21 study is a reminder that the science of obesity is complex and multifaceted, and that there is no single solution to this complex problem.
Author: Evan Null
